Although many of the mechanisms controlling normal cell growth and differentiation remain unclear, a variety of factors have been found to influence these processes. In particular, numerous reports have suggested that glycoconjugate structures both on the cell surface and in the environmental substrate are important determinants of cell adhesion (Yamada & Olden, 1978; Schubert & LaCorbiere, 1980) , intercellular interaction (Ocklind et al., 1980) , differentiation (Fukuda et al., 1980) and cell growth (Hatten, 1981; Stanley & Sudo, 1981) . In addition, it has been suggested that other agents that influence normal and malignant cell 0306-3283/82/110249-1 1$01.50/1 1982 The Biochemical Society growth, such as growth factors (e.g. epidermal growth factor) and peptide hormones (e.g. insulin), exert their effects by interaction with cell-surface glycoprotein receptors (Ronnett & Lane, 1981; Hedo et al., 1981) . It is therefore possible that many of the alterations in growth and differentiation found in transformed and malignant cells are mediated via alteration in glycoconjugate structures. Numerous studies have demonstrated changes in the glycoprotein content of transformed cells when compared with their non-transformed counterparts, but the function of the oligosaccharide moieties of glycoproteins remains uncertain (see, e.g., Buck et al., 1970 Buck et al., , 1971 Smets et al., 1976; Blithe et al., 1980; Sherblom & Carraway, 1980 ).
We have previously described the purification from human malignant effusions of a low-molecular-weight glycoprotein (M, approx. 3600) (termed cancer-associated galactosyltransferase acceptor, CAGA glycoprotein) that may serve as an acceptor substrate for a transformation-associated galactosyltransferase (Podolsky et al., 1978) . The glycoprotein has been shown to contain mannose and N-acetylglucosamine residues as well as a peptide backbone (Podolsky & Weiser, 1979) . This glycoprotein was found to cause profound inhibition of cell growth, leading to cell death, when added to media of transformed cells in culture (Podolsky et al., 1978; Podolsky & Isselbacher, 1980) . In contrast, non-transformed cells were unaffected by addition of CAGA glycoprotein. In addition, administration of CAGA glycoprotein to hamsters inoculated with tumorigenic cells was found to prevent tumour development or cause actual tumour regression.
The mechanism whereby the glycoprotein leads to selective killing of transformed cells in vitro and in vivo and the relationship to its action as a galactosyltransferase substrate remain uncertain. In the present paper we describe results of binding studies with 3H-labelled CAGA glycoprotein. The glycoprotein was found to bind specifically through its carbohydrate moiety. However, studies in chickembryo fibroblasts (CEF cells) (v/v) heatinactivated (65°C, 20min) foetal calf serum as well as penicillin and streptomycin. Cells from second to ninth passage were grown to semi-confluence for harvesting or use in CAGA-glycoprotein growthinhibition assays. Primary CEF-cell cultures were prepared from pathogen-free 10-day chick embryos as previously described (Inui et al., 1980) and maintained at 410C. Secondary cultures were infected on day 3 after seeding with a temperaturesensitive RSV mutant (Ts68) maintained in this laboratory (2 plaque-forming units/cell by focus plaque assay). Infected cells were either maintained at 410C (non-permissive temperature) or transferred to 370C (permissive temperature) 24h after infection. Cells from semi-confluent dishes were either harvested in the presence of EDTA and trypsin or used for CAGA-glycoprotein growthinhibition assay.
CAGA-glycoprotein growth-inhibition assays were performed on semi-confluent dishes (35 mm and 60mm) with purified glycoprotein (see below) added in sterile deionized water (25-100,ul/dish).
Inhibition was scored at 24 h by microscopic evaluation and cell counts. Viability was assessed by incorporation of [3Hlthymidine (lO,uCi/dish; specific radioactivity 80 Ci/mmol; New England Nuclear Corp.) after addition of the labelled precursor 2h before harvesting; at the end of that time cells were harvested by brief trypsimization and then washed twice in phosphate-buffered saline (0.154 M-NaCl/ 10mM-sodium phosphate buffer, pH7.2). This was followed by the addition of ice-cold trichloroacetic acid to 10% (w/v) final concentration. The resulting precipitate was collected on glass-fibre filters and washed twice with 10% trichloroacetic acid followed by ice-cold 100% ethanol, and incorporated radioactivity was determined in lOml of toluene/1,4-bis-(5-phenyloxazol-2-yl)benzene scintillant (New England Nuclear Corp.) . Viability was also determined by the ability to exclude Trypan Blue (1%, w/v) after 5 min. Preparation of CAGA glycoprotein and 3H-labelled CAGA glycoprotein Purified CAGA glycoprotein was prepared from malignant human effusions as previously described (Podolsky & Weiser, 1979) . Tritiated CAGA glycoprotein was prepared by reductive methylation by using a modification of a described method (Gregoriadis & Ryman, 1978) . CAGA glycoprotein (20mg) was dissolved in 1.2ml of 0.2M-sodium borate buffer, pH9.0, and cooled on ice. NaBH4 (0.5 mg) containing NaB3H4 (3.3 mCi; New England Nuclear Corp.) was added in a volume of 10ul. Subsequently 1.0p1 portions of 37% (v/v) formaldehyde were added at 5min intervals over 1982 30min. The reaction mixture was then applied to a column (1.5 cm x 30 cm) of Bio-Gel P-2 (100-200 mesh) equilibrated in deionized water; the column was developed at a rate of approx. 15 ml/h, 4 ml fractions being collected; radioactivity was counted in lOp1 samples dissolved in lOml of Aquasol scintillation fluid (New England Nuclear Corp.). Fractions containing 3H-labelled CAGA glycoprotein (material in excluded volume) were pooled, dried under N2 and redissolved in 1.0ml of O.lM-acetic acid to destroy any remaining hydride. The 3H-labelled CAGA glycoprotein (specific radioactivity 2.6 x 107c.p.m./mg) was freeze-dried and stored at -20°C before use.
The homogeneity of the labelled glycopeptide was compared with that of the unlabelled species by chromatography on Bio-Gel P-4. 3H-labelled or unlabelled CAGA glycoprotein (10mg) was dissolved in 2.5 mM-pyridine/acetate buffer, pH 5.5, and applied to a column (1.5 cm x 100 cm) of Bio-Gel P-4, which was developed at a rate of 7.0ml/h, 2.5 ml fractions being collected. The column was monitored for absorbance at 280nm, and hexose was determined by the phenol/H2SO4 method (Dubois et al., 1956 (Tai et al., 1975 Glasgow et al. (1977) . Intact 3H-labelled CAGA glycoprotein was exhaustively digested with Pronase (GIBCO; 75500 PUK units/mg) (1 PUK unit of Pronase is defined as the amount liberating 1 pmol of tyrosine from casein/min at pH7.5 at 370C); 20mg (107c.p.m.) of CAGA glycoprotein was dissolved in 2.5 ml of 50mM-Tris/HCl buffer, pH 7.6, containing lOmM-CaCl2; Pronase (2.5 mg) was then added and the mixture was incubated at 45°C; a drop of toluene was added to retard bacterial growth. After 24 h an additional 1.5 mg of Pronase was added and incubation was continued. After an additional 24h, the mixture was applied to a column (2.5 cm x Vol. 208 100cm) of Bio-Gel P4 and developed with 20mM-pyridine/acetate buffer, pH5.5, at a rate of lOml/h; 2.5ml fractions were collected and monitored for radioactivity and hexose as above. Hexose-containing fractions were pooled, freeze-dried and redissolved in 2.5ml of 50mM-Tris/HCl buffer, pH7.6, containing lOmM-CaCl2. After addition of 2.5 mg of Pronase, digestion was again continued for 24h at 450C before re-chromatography on Bio-Gel P4 as above. Again hexose-containing fractions were pooled, and after these had been freeze-dried a third Pronase digestion performed for 24 h followed by chromatography on Bio-Gel P-4 as above. Hexose-containing fractions, which were devoid of any radiolabel, were pooled and freeze-dried. Carbohydrate and amino acid compositions were determined by g.l.c. as previously described (Podolsky & Weiser, 1979) .
CNBr-activated Sepharose 4B was purchased from Pharmacia; 2g was swollen and washed with 1 mM-HCl. Unlabelled (20mg) and labelled CAGA glycoprotein (3 x 106 c.p.m.) were dissolved in 0.1 MNaHCO3, added to moist gel, and incubated with shaking at room temperature for 2h followed by incubation at 0-40C overnight. The gel was washed several times with 0.1 M-NaHCO3 and then suspended in 1 M-ethanolamine for 2 h at room temperature. The prepared gel was then washed successively with three cycles of 0.1 M-sodium acetate buffer, pH 4.0, alternating with 0.1 M-sodium borate buffer, pH 8.0. The gel was finally washed and suspended in either distilled water or phosphatebuffered saline.
Results
The CAGA glycoprotein was labelled by exhaustive reductive methylation. The tritiated preparation was found to co-chromatograph with unlabelled CAGA glycoprotein on Bio-Gel P-4 ( Fig.  1) Fraction no. Fig. 1 . Chromatography of 3H-labelled CA GA glycoprotein on Bio-Gel P-4 3H-labelled CAGA glycoprotein was prepared as described in the text and twice chromatographed on Bio-Gel P-2 to remove unchanged NaB3H4. Freeze-dried 3H-labelled CAGA glycoprotein (1 x 105c.p.m./lOpUl) and unlabelled CAGA glycoprotein (10mg/200,u1) were applied together to a column (1.5cm x 100cm) of Bio-Gel P-4 equilibrated in 2.5 mM-pyridine/acetate buffer, pH 5.5. The column was developed at a flow rate of 7 ml/h, 2.5 ml fractions being collected under continuous u.v. monitoring at 280nm ( ). Hexose was determined by the phenol/H2SO4 method (Dubois et al., 1956 ) at 490nm (------) . Samples (100,ul) (Fig. 3) . However, the transformed BHKpy (CAGA-glycoprotein-sensitive) cells bound 4-5 times more 3H-labelled CAGA glycoprotein than did the non-transformed BHK cell line (Table  1) .
Studies on the effect of CAGA glycoprotein on cell growth, morphology and [3Hithymidine incorporation were performed with secondary CEF cells, as well as CEF cells infected with a temperature-sensitive RSV mutant (Ts68) grown at 370C and 410C. As shown in Table 2 glycoprotein at 410 C were subsequently shifted to 37°C, cell killing was observed at 24 h, the time necessary for expression of transformation, despite a change to non-CAGA-glycoprotein containing media before the shifting of the temperature ( Table 3 , none of the monosaccharides tested resulted in significant inhibition of the binding of 3H-labelled CAGA glycoprotein. Similarly a variety of amino acids failed to inhibit binding. Subsequently, the effects of CAGA-O oligosaccharide and CAGA-O(Asn) glycopeptide were examined. Treatment with endoglucosaminidase H successfully removed carbohydrate from the tritiated peptide backbone. The isolated oligosaccharide moiety and the peptide backbone (with N-acetylglucosamine attached) were separated and isolated by chromatography on Bio-Gel P-4 after the endoglucosaminidase H treatment (Fig. 4) . The intact glycoprotein was found to be resistant to treatment with endoglucosaminidase D prepared in this laboratory (results not shown). A CAGA-O(Asn) glycopeptide fragment was also prepared, by exhaustive Pronase digestion of the intact glycoprotein followed by chromatography on Bio-Gel P-4 (Fig. 5) Fraction no. Fig. 5 . Isolation ofCA GA-O(Asn) glycopeptidefrom 3H-labelled CAGA glycoprotein after Pronase digestion 3H-labelled CAGA glycoprotein (20mg; 107c.p.m.) was dissolved in 2.5 ml of 50mM-Tris/HCI buffer, pH 7.6, containing lOmM-CaCl2, and Pronase (2.5mg) was added before incubation at 45°C; after 24h 1.5mg of Pronase was added and digestion continued for 24h at 450C. The reaction mixture was applied to a column (1.5cm x 100cm) of Bio-Gel P-4, which was developed with 2.0mM-pyridine/acetate buffer, pH5.5, at 10ml/h, 2.5ml fractions being collected with constant monitoring at 280nm ( ). Hexose was determined on 200,1 samples by the phenol/ H2SO4 method (------). Radioactivity assessed of 100 jul samples dissolved in 5.Oml of Aquasol II (--). Hexosecontaining fractions were pooled and subjected to further Pronase digestion as described in the text. glycopeptide Carbohydrate and amino acid analysis was performed by g.l.c. on a Varian 6000 gas chromatograph in tandem with a Hewlett Packard 3390A integrator by using previously described methods (Podolsky & Weiser, 1975 , 1979 Time after addition of 3H-labelled CAGA glycoprotein (h) Fig. 7 In recent years numerous factors have been described that appear to promote or retard the growth of transformed cells in vitro and in vivo. These factors range from low-molecular-weight tumour promotors and peptides (see, e.g., Becker & Cook, 1981; Heifetz & Prager, 1981) to larger polypeptide hormones and growth factors (see, e.g., Im et al., 1978; Todaro et al., 1980; Sutherland et al., 1981; Donahoe et al., 1981) . Reports from this laboratory previously described the presence in human malignant effusions of a low-molecular-weight galactosyltransferase acceptor (cancer-associated galactosyltransferase acceptor; CAGA glycoprotein) that specifically inhibited the growth of transformed cells in vitro and at least one solid tumour in vivo (Podolsky et al., 1978; Podolsky & Isselbacher, 1980) . This inhibitor was purified to apparent homogeneity and found to be a glycoprotein containing, almost exclusively, glucosamine and mannose in its carbohydrate moeity (Podolsky & Weiser, 1979) . The specificity of the binding of CAGA glycoprotein to transformed cells and some of the early effects of CAGA glycoprotein that ultimately lead to cell death were investigated in the present studies.
The present studies provide further observations on the association of CAGA-glycoprotein-induced cell killing with the transformed state. Thus, as shown in Fig. 3 , infection of CEF cells with a temperature-sensitive RSV mutant was in itself insufficient to induce sensitivity of the infected cells to CAGA glycoprotein; killing was seen only at the permissive temperature (370C), and the time course for 'sensitivity' to CAGA glycoprotein was comparable with that required for the expression of transformation.
Binding studies with 3H-labelled CAGA glycoprotein indicated that CAGA-glycoprotein-sensitive cells bound 4-5-fold more glycoprotein than did those resistant to this inhibitor. However, it is evident from the present study that increased binding of CAGA glycoprotein was not the only distinguishing feature between sensitive (transformed) and resistant (non-transformed) cell types. Of particular interest is the observation that CEF-RSV (41 0C) cells did not demonstrate CAGA-glycoprotein-sensitivity (i.e. cell death), although they appeared to bind sufficient 3H-labelled CAGA glycoprotein to lead to inhibition of growth since these same cells were killed when shifted to 370C without any further exposure to CAGA glycoprotein. Thus specific binding of CAGA glycoprotein appears to be necessary, but not in itself sufficient, to make a cell susceptible to the CAGA-glycoprotein-induced cytotoxic effect. It is of further interest that preliminary Scatchard-plot analysis suggests a uniform set of receptors with similar association constants on both CAGA-glycoprotein-sensitive and -insensitive cells, indicating that differential binding may indeed be due primarily to quantitative differences.
Although CAGA glycoprotein appears to bind initially at the cell surface, as determined by sensitivity to limited proteinase treatment, the progressive decline in the amount of CAGA glycoprotein solubilized by such treatment suggests that the bound glycoprotein may be internalized over a period of 4h, thus making it inaccessible to an exogenous proteinase. Alternatively the progressive resistance to solubilization by trypsin could have resulted from a change in the conformation or distribution of the glycoprotein and its receptor in the cell membrane rendering CAGA glycoprotein resistant to release by the proteinase. The inability of CAGA-Sepharose 4B to induce cell killing supports the concept that CAGA glycoprotein must be internalized; however, this lack of efficacy might also have resulted from the Sepharose-bound CAGA glycoprotein preventing conformational or distributional changes because of the fixed nature of the ligand. It is noteworthy, however, that the 4h period leading to complete resistance to trypsininduced solubilization of CAGA glycoprotein is comparable with the time during which the cytotoxic effect of CAGA glycoprotein remained reversible (Fig. 7) .
1982
It appears that both oligosaccharide and peptide components are needed for the biological activity of CAGA glycoprotein. Thus results of competitiveinhibition experiments suggest that specific binding is mediated through the oligosaccharide chain, whether prepared as the free oligosaccharide by endoglucosaminidase H treatment or as the asparagine-bound species prepared by exhaustive Pronase digestion. It is noteworthy, however, that the component monosaccharides as such failed to cause significant inhibition of the binding of 3H-labelled CAGA glycoprotein, suggesting that the CAGA-glycoprotein-binding site requires a more extended carbohydrate structure. However, the oligosaccharide produced by endoglucosaminidase H treatment was incapable of causing growth inhibition and cell death, suggesting that the peptide backbone is needed for full expression of growth inhibition. Although the oligosaccharide plays an important role in the binding of 3H-labelled CAGA glycoprotein, the relationship between ability of CAGA glycoprotein to function as a galactosyltransferase acceptor substrate and as a growth inhibitor remains unclear.
In summary, these present studies demonstrate that CAGA-glycoprotein-sensitive cells specifically bind the glycoprotein through its oligosaccharide moiety and suggest that the binding of CAGA glycoprotein is followed by internalization of the glycoprotein. These studies also suggest that the explanation of the apparent specificity of the effects of CAGA glycoprotein on the transformed state may be related, at least in part, to events subsequent to these initial processes.
